Akaltun I, Kara SS, Kara T (2018) The relationship between toxoplasma gondii IgG antibodies and generalized anxiety disorder and obsessive-compulsive disorder in children and adolescents: a new approach. Nord J Psychiatry 72(1):57–62

Article  PubMed  Google Scholar 

Antonietta V, Giovanni T, Andreas MG et al (2014) Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution. J Control Release 174:195–201

Article  Google Scholar 

Aouizerate B, Haffen E (2019) New research in obsessive-compulsive disorder and major depression. Brain Sci 9(6):140

Article  PubMed  PubMed Central  Google Scholar 

Arcela TL, Leonardo DDF, Larissa BT et al (2021) Highlights in targeted nanoparticles as a delivery strategy for glioma treatment. Int J Pharm 604:120758

Article  Google Scholar 

Attwells S, Setiawan E, Wilson AA, Rusjan PM, Mizrahi R, Miler L, Xu C, Richter MA, Kahn A, Kish SJ, Houle S, Ravindran L, Meyer JH (2017) Inflammation in the neurocircuitry of obsessive-compulsive disorder. JAMA Psychiat 74(8):833–840

Article  Google Scholar 

Bayramgurler D, Karson A, Ozer C, Utkan T (2013) Effects of long-term etanercept treatment on anxiety- and depression-like neurobehaviors in rats. Physiol Behav 119:145–148

Article  CAS  PubMed  Google Scholar 

Bhatt S, Shukla P, Raval J, Goswami S (2016) Role of aspirin and dexamethasone against experimentally induced depression in rats. Basic Clin Pharmacol Toxicol 119(1):10–18

Article  CAS  PubMed  Google Scholar 

Brander G, Perez-Vigil A, Larsson H, Mataix-Cols D (2016) Systematic review of environmental risk factors for obsessive-compulsive disorder: a proposed roadmap from association to causation. Neurosci Biobehav Rev 65:36–62. https://doi.org/10.1016/j.neubiorev.2016.03.011

Article  PubMed  Google Scholar 

Brondino N, De SA, Re S et al (2013) A systematic review and meta-analysis of ginkgo biloba in neuropsychiatric disorders: from ancient tradition to modern-day medicine. Evid Based Complement Alternat Med 2013:915691

Article  PubMed  PubMed Central  Google Scholar 

Brown KD, Farmer C, Freeman GM Jr, Spartz EJ, Farhadian B, Thienemann M, Frankovich J (2017) Effect of early and prophylactic nonsteroidal anti-inflammatory drugs on flare duration in pediatric acute-onset neuropsychiatric syndrome: an observational study of patients followed by an academic community-based pediatric acute-onset neuropsychiatric syndrome clinic. J Child Adolesc Psychopharmacol 27(7):619–628

Article  CAS  PubMed  PubMed Central  Google Scholar 

Camfield DA, Sarris J, Berk M (2011) Nutraceuticals in the treatment of obsessive compulsive disorder (OCD): a review of mechanistic and clinical evidence. Prog Neuropsychopharmacol Biol Psychiatry 35(4):887–895

Article  PubMed  Google Scholar 

Chimakurthy J, Murthy TE (2010) Effect of curcumin on quinpirole induced compulsive checking: an approach to determine the predictive and construct validity of the model. N Am J Med Sci 2(2):81–86

PubMed  PubMed Central  Google Scholar 

Cleveland WL, DeLaPaz RL, Fawwaz RA, Challop RS (2009) High-dose glycine treatment of refractory obsessive-compulsive disorder and body dysmorphic disorder in a 5-year period. Neural Plast 2009:768398. https://doi.org/10.1155/2009/768398

Cong W, Dong W, Bai L et al (2015) Seroprevalence and associated risk factors of toxoplasma gondii infection in psychiatric patients: a case-control study in eastern China. Epidemiol Infect 143(14):3103–9

Article  CAS  PubMed  Google Scholar 

Costa DLC, Diniz JB, Requena G et al (2017) Randomized, double-blind, placebo-controlled trial of N-acetylcysteine augmentation for treatment-resistant obsessive-compulsive disorder. J Clin Psychiatry 78(7):766–773

Article  Google Scholar 

David XM, Eugene PC, Bowser R, Rachael WS (2019) Lipid and polymer blended polyester nanoparticles loaded with adapalene for activation of retinoid signaling in the CNS following intravenous administration. J Drug Deliv Sci Technol 52:927–933

Article  Google Scholar 

Del CA, Sorice S, Padovano A et al (2019) Psychopharmacological treatment of obsessive-compulsive disorder (OCD. Curr Neuropharmacol 17(8):710–736

Article  Google Scholar 

Dietrich DE, Zhang Y, Bode L et al (2005) Brain potential amplitude varies as a function of Borna disease virus-specific immune complexes in obsessive-compulsive disorder. Mol Psychiatry 10(6):519–520

Article  Google Scholar 

Dowlati Y, Herrmann N, Swardfager W et al (2010) A meta-analysis of cytokines in major depression. Biol Psychiat 67(5):446–457

Article  CAS  PubMed  Google Scholar 

Empana JP, Sykes DH, Luc G et al (2005) Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men. Circulation 111:2299–2305

Article  CAS  PubMed  Google Scholar 

Ersan S, Bakir S, Erdal EE, Dogan O (2006) Examination of free radical metabolism and antioxidant defence system elements in patients with obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry 30(6):1039–1042

Article  CAS  PubMed  Google Scholar 

Esalatmanesh S, Abrishami Z, Zeinoddini A et al (2016) Minocycline combination therapy with fluvoxamine in moderate-to-severe obsessivecompulsive disorder: a placebo-controlled, double- blind, randomized trial. Psychiatry Clin Neurosci 70(11):517–526

Article  CAS  PubMed  Google Scholar 

Fenske JN, Petersen K (2015) Obsessive-compulsive disorder: diagnosis and management. Am Fam Physician 92(10):896–903

PubMed  Google Scholar 

Flanagan TW, Nichols CD (2018) Psychedelics as anti-inflammatory agents. Int Rev Psychiatry 30:363–375

Article  PubMed  Google Scholar 

Flegr J, Horacek J (2017) Toxoplasma-infected subjects report an obsessive-compulsive disorder diagnosis more often and score higher in obsessive-compulsive inventory. Eur Psychiatry 40:82–7

Article  CAS  PubMed  Google Scholar 

Garabadu D, Kumar V (2019) Celecoxib potentiates the antianxiety and anticompulsive-like activity of fluoxetine against chronic unpredictable mild stress in experimental animals. Behav Pharmacol 30(2&3):251–259

Article  CAS  PubMed  Google Scholar 

Garvey MA, Perlmutter SJ, Allen AJ et al (1999) A pilot study of penicillin prophylaxis for neu-ropsychiatric exacerbations triggered by streptococcal infections. Biol Psychiatry 45(12):1564–71

Article  CAS  PubMed  Google Scholar 

Gerentes M, Pelissolo A, Rajagopal K et al (2019) Obsessive-compulsive disorder: autoimmunity and neuroinflammation. Curr Psychiatry Rep 21(8):78. https://doi.org/10.1007/s11920-019-1062-8

Article  PubMed  Google Scholar 

Ghanizadeh A, Mohammadi MR, Bahraini S et al (2017) Efficacy of N-acetylcysteine augmentation on obsessive compulsive disorder: a multicenter randomized double blind placebo controlled clinical trial. Iran J Psychiatry 12(2):134–141

PubMed  PubMed Central  Google Scholar 

Gray SM, Bloch MH (2012) Systematic review of proinflammatory cytokines in obsessive-compulsive disorder. Curr Psychiatry Rep 14(3):220–228

Article  PubMed  PubMed Central  Google Scholar 

Hannestad J, DellaGioia N, Bloch M (2011) The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology 36(12):2452–2459. https://doi.org/10.1038/npp.2011.132

Article  CAS  PubMed  PubMed Central  Google Scholar 

Haroon HB, Mukherjee D, Anbu J, Teja BV (2021) Thiolated chitosan-centella asiatica nanocomposite: a potential brain targeting strategy through nasal route. AAPS Pharm Sci Tech 22(8):251

Article  CAS  Google Scholar 

Harshvardhan J, Prabhakar B, Pravin S (2022) Modulation of olfactory area for effective transportation of actives in CNS disorders. J Drug Deliv Sci Technol 68:103091

Article  Google Scholar 

Harvey BH, Brink CB, Seedat S, Stein DJ (2002) Defining the neuromolecular action of myo-inositol: application to obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry 26(1):21–32

Article  CAS  PubMed  Google Scholar 

Hettema JM, Prescott CA, Myers JM et al (2005) The structure of genetic and environmental risk factors for anxiety disorders in men and women. Arch Gen Psychiatry 62(2):182–189

Article  PubMed  Google Scholar 

https://www.intechopen.com/chapters/46477. Accessed 28 Nov 2022. https://medicalxpress.com/news/2014-10-aspirin-shown-benefit-schizophrenia-treatment.html. Accessed 30 Nov 2022

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088283/#REF4 Accessed 30 Nov 2022

https://www.nhs.uk/mental-health/conditions/obsessive-compulsive-disorder-ocd/overview/. Accessed 1 Dec 2022

https://www.singlecare.com/blog/news/ocd-statistics/. Accessed 1 Dec 2022

Jabri Karoui I, Marzouk B (2013) Characterization of bioactive compounds in Tunisian bitter orange (Citrus aurantium L.) peel and juice and determination of their antioxidant activities. Biomed Res Int 2013:345415. https://doi.org/10.1155/2013/345415

Jahanbakhsh SP, Manteghi AA, Emami SA (2016) Evaluation of the efficacy of Withania somnifera (Ashwagandha) root extract in patients with obsessive-compulsive disorder: a randomized double-blind placebo-controlled trial. Complement Ther Med 27:25–29

Article  PubMed  Google Scholar 

Jezova D, James PH (2020) Stress and stress-related disease states as topics of multi-approach research. Stress 23(6):615–616

Article  PubMed  Google Scholar 

Jimenez-Jimenez FJ, Alonso-Navarro H, Garcia-Martin E, Agundez JAG (2020) Anti-inflammatory effects of amantadine and memantine: possible therapeutics for the treatment of covid-19? J Pers Med 10(4):217

Article  PubMed  PubMed Central  Google Scholar 

Kaurav BPS, Wanjari MM, Chandekar A et al (2012) Influence of Withania somnifera on obsessive compulsive disorder in mice. Asian Pac J Trop Med 5(5):380–384

Article